Medisca Founder Antonio Dos Santos Returns As CEO
KUALA LUMPUR, June 30 (Bernama) -- Medisca has appointed founder and chairman Antonio Dos Santos as chief executive officer (CEO), succeeding Sanjay Goorachurn as part of the company's leadership transition.
Dos Santos, who founded the pharmaceutical compounding company more than 35 years ago, will oversee Medisca's long-term strategy, including global expansion, investment in new growth areas and strengthening strategic partnerships.
Dos Santos said the company's founding purpose continues to guide its long-term direction.
"As we begin this next chapter, we will keep investing in our people, our partnerships, and the innovation that will help shape the future of Medisca and the pharmaceutical compounding industry," he said in a statement.
Working alongside Vice-Chair Maria Zaccardo and the company's executive leadership team, Dos Santos will continue guiding Medisca's strategic direction as it expands its global operations and invests in its long-term growth.
Medisca thanked Goorachurn for his contributions to the organisation and wished him success in his future endeavours.
As Medisca continues to grow globally, the company remains committed to empowering personalised wellness for all by expanding the products, technologies, education, and expertise that help healthcare professionals deliver better patient care worldwide.
-- BERNAMA
Latest News
- S. Korea's Overseas Direct Investment Continues To Grow In Q1
- Rocket Engine To Power China's Reusable Launch Vehicle Completes Long-Duration Test
- S. Korea Postpones Plan To Launch Solid-Fuel Space Rocket Over Safety Concerns
- Shell Sees Global LNG Trade Flat In 2026 As Hormuz Disruption Hits Supply
- Chinese Billionaire Gets 30 Years In US Prison For Fraud